Thrombocytopenia associated with intravenous desferrioxamine
- PMID: 4050784
- DOI: 10.1016/s0272-6386(85)80183-9
Thrombocytopenia associated with intravenous desferrioxamine
Abstract
Desferrioxamine (DFO) was administered intravenously to a 63-year-old chronic hemodialysis patient with osteomalacia believed secondary to aluminum intoxication. Thrombocytopenia was noted after five doses of DFO. Platelet counts normalized after DFO was withheld. Thrombocytopenia recurred upon two rechallenges with this drug. It is suggested that platelet counts be monitored in hemodialysis patients receiving intravenous DFO.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
